Skip to main content
. 2016 Feb 25;352:i708. doi: 10.1136/bmj.i708

Table 1.

Baseline characteristics. Values are numbers (percentages) unless stated otherwise

Characteristics All participants Participants with systolic blood pressure recorded at 12 months
Intensive target (n=266) Standard target (n=263) Intensive target (n=182) Standard target (n=197)
Mean (SD) age, years 71.9 (9.1) 71.7 (9.4) 72.6 (8.3) 71.9 (9.5)
Male sex 157 (59) 156 (59) 104 (57) 125 (63)
White ethnicity 260 (98) 259 (98) 180 (99) 194 (98)
Current smoker 25 (9) 33 (13) 15 (8) 27 (14)
Mean (SD) SBP, mm Hg 142.9 (14.0) 142.2 (13.4) 143.5 (13.5) 142.2 (12.9)
 SBP <140 mm Hg 128 (48) 129 (49) 79 (43) 98 (50)
 SBP ≥140 mm Hg 138 (52) 134 (51) 103 (57) 99 (50)
Mean (SD) diastolic blood pressure, mm Hg 79.9 (10.0) 80.4 (9.8) 78.8 (9.3) 80.7 (10.1)
Diabetes mellitus 26 (10) 25 (10) 19 (10) 21 (11)
Atrial fibrillation 28 (11) 27 (10) 21 (12) 22 (11)
Coronary heart disease 41 (15) 46 (17) 28 (15) 35 (18)
Chronic kidney disease 26 (10) 30 (11) 19 (10) 23 (12)
Heart failure 2 (1) 7 (3) 1 (1) 6 (3)
Peripheral vascular disease 11 (4) 11 (4) 7 (4) 6 (3)
Stroke 130 (49) 122 (46) 85 (47) 95 (48)
Transient ischaemic attack only 135 (51) 141 (54) 97 (53) 102 (52)
Mean (SD) No of antihypertensive drugs 1.0 (0.8) 1.1 (0.8) 1.1 (0.8) 1.1 (0.8)
Mean (SD) No of other drugs 4.5 (2.5) 4.6 (2.6) 4.5 (2.5) 4.6 (2.6)
Mean (SD) total No of drugs 5.6 (2.8) 5.7 (2.7) 5.6 (2.7) 5.7 (2.7)
Modified Rankin scale*:
 0 or 1 135 (518) 125 (48) 98 (54) 84 (43)
 2 65 (24) 69 (26) 42 (23) 57 (29)
 3 or 4 47 (18) 51 (19) 29 (16) 42 (21)

SBP=systolic blood pressure.

*Data missing for 19 patients in intensive arm and 18 in standard arm (all participants) and for 13 patients in intensive arm and 14 in standard arm (participants with 12 month systolic blood pressure).